SOTERA HEALTH COMPANY Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
SOTERA HEALTH COMPANY (SHC) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $14.57 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2025-02-27
- SOTERA HEALTH COMPANY share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-03-31 was $20.03, a 23.72% decline year-over-year.
- SOTERA HEALTH COMPANY share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2021-03-31 was $26.26.
- SOTERA HEALTH COMPANY share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $14.57, a 16.84% decline from fiscal 2023.
- SOTERA HEALTH COMPANY share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $17.52, a 57.98% increase from fiscal 2022.
- SOTERA HEALTH COMPANY share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $11.09, a 53.11% decline from fiscal 2021.
- SOTERA HEALTH COMPANY share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $23.65.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2024-12-31 | $14.57 10-K · filed 2025-02-27 | |||
| 2023-12-31 | $17.52 10-K · filed 2024-02-27 | |||
| 2023-09-30 | $17.53 10-Q · filed 2023-11-01 | |||
| 2022-12-31 | $11.09 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $19.96 10-Q · filed 2022-11-02 | |||
| 2022-06-30 | $20.03 10-Q · filed 2022-08-04 | |||
| 2022-03-31 | $20.03 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | $23.65 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $24.70 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | $24.73 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | $26.26 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |